» Authors » Mirjana Stancic

Mirjana Stancic

Explore the profile of Mirjana Stancic including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 205
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
de Jong C, Stancic M, Pinxterhuis T, van Horssen J, Van Dam A, Gabius H, et al.
J Neuropathol Exp Neurol . 2018 Sep; 77(11):1024-1038. PMID: 30252090
Neuron-derived molecules are potent regulators of oligodendrocyte differentiation and myelination during brain development and upon demyelination. Their analysis will thus contribute to understanding remyelination failure in demyelinating diseases, such as...
2.
Stoffels J, de Jonge J, Stancic M, Nomden A, van Strien M, Ma D, et al.
Brain . 2013 Feb; 136(Pt 1):116-31. PMID: 23365094
Remyelination following central nervous system demyelination is essential to prevent axon degeneration. However, remyelination ultimately fails in demyelinating diseases such as multiple sclerosis. This failure of remyelination is likely mediated...
3.
Stancic M, Slijepcevic D, Nomden A, Vos M, de Jonge J, Sikkema A, et al.
Glia . 2012 Mar; 60(6):919-35. PMID: 22431161
Myelination of axons by oligodendrocytes (OLGs) is essential for proper saltatory nerve conduction, i.e., rapid transmission of nerve impulses. Among others, extracellular matrix (ECM) molecules, neuronal signaling, and axonal adhesion...
4.
Czepiel M, Balasubramaniyan V, Schaafsma W, Stancic M, Mikkers H, Huisman C, et al.
Glia . 2011 Mar; 59(6):882-92. PMID: 21438010
The technology to generate autologous pluripotent stem cells (iPS cells) from almost any somatic cell type has brought various cell replacement therapies within clinical research. Besides the challenge to optimize...